Monday, February 07, 2022
Why the Sudden Hostility Toward Off-Label Medicines?
Why the Sudden Hostility Toward Off-Label Medicines?: The US Food and Drug Administration has an exhaustive process, “to evaluate new drugs before they can be sold.” Specifically, this involves the Center for Drug Evaluation and Research (CDER). The rationale is sound and for the general goo...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment